Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA approves Recarbrio for hospital-acquired and ventilator-associated bacterial pneumonia

June 5, 2020

Meiji Seika Pharma discontinues development of ME-1111 for treatment of onychomycosis

June 5, 2020

Identification of inhibitors of the main protease of SARS-CoV-2

June 5, 2020

Forge Therapeutics patents bacterial LpxC inhibitors

June 5, 2020

PharmAust reports preliminary data for monepantel in models of SARS-CoV-2 infection

June 5, 2020

Intravacc announces partnership to develop intranasal COVID-19 vaccine

June 5, 2020

Inovio and partners to initiate phase I/II study of COVID-19 DNA vaccine in South Korea

June 5, 2020

ValiRx collaborates with Oncolytika and Black Cat Bio to explore combination treatment for COVID-19

June 5, 2020

Data questions arise for two major COVID-19 studies

June 4, 2020

New monobactam compounds presented by Nanjing Sanhome Pharmaceutical

June 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...